Pharma News

SAN DIEGO, Dec.

Cancer is the second leading cause of death worldwide and estimates of its burden around the globe are vital for cancer control planning.

CANBERRA, Dec.

A late-breaking abstract being presented today during the 58th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego shows patients who experience graft-versus-host d...

Novo Nordisk has filed its once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide with regulators on both sides of the Atlantic, seeking permission to market the drug for the treatme...

In a step aimed at preventing future outbreak of diseases such as dengue, Zika and chikungunya, researchers in Brazil have developed a test that analyses clinical samples from patients to diagnose inf...

Experts at the University of Edinburgh have pinpointed more than 30 infections that are likely candidates for the next major pandemic.

Patients in the UK with severe asthma are on course to be able to receive treatment with GlaxoSmithKline's recently approved Nucala drug.

We know that hedge funds generate strong risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors.

The market for seasonal influenza vaccines, which is set to hit $4.

The Israeli pharmaceutical market is set to rise from $1.

NEW YORK, NY, USA I December 1, 2016 I Pfizer Inc.